Marcello Casertano

Dr. Marcello Casertano

Department of PharmacyUniversity of Napoli Federico IIVia Domenico Montesano 4980131, Napoli, Italy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
Marcello CasertanoMarcello Casertano
Marcello Casertano
Marialuisa MennaMarialuisa Menna
Marialuisa Menna
Concetta ImperatoreConcetta Imperatore
Concetta Imperatore
Among the sub-phylum of Tunicate, ascidians represent the most abundant class of marine invertebrates, with 3000 species by heterogeneous habitat, that is, from shallow water to deep sea, already reported. The chemistry of these sessile filter-feeding organisms is an attractive reservoir of varied and peculiar bioactive compounds. Most secondary metabolites isolated from ascidians stand out for their potential as putative therapeutic agents in the treatment of several illnesses like microbial infections. In this review, we present and discuss the antibacterial activity shown by the main groups of ascidian-derived products, such as sulfur-containing compounds, meroterpenes, alkaloids, peptides, furanones, and their derivatives. Moreover, the direct evidence of a symbiotic association between marine ascidians and microorganisms shed light on the real producers of many extremely potent marine natural compounds. Hence, we also report the antibacterial potential, joined to antifungal and antiviral activity, of metabolites isolated from ascidian-associate microorganisms by culture-dependent methods.

14 February 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Concetta ImperatoreConcetta Imperatore
Concetta Imperatore
RGRoberto Gimmelli
Roberto Gimmelli
MPMarco Persico
Marco Persico
Marcello CasertanoMarcello Casertano
Marcello Casertano
AGAlessandra Guidi
Alessandra Guidi
Marialuisa MennaMarialuisa Menna
Marialuisa Menna
The chemical analysis of the sponge Dysidea avara afforded the known sesquiterpene quinone avarone, along with its reduced form avarol. To further explore the role of the thiazinoquinone scaffold as an antiplasmodial, antileishmanial and antischistosomal agent, we converted the quinone avarone into the thiazinoquinone derivative thiazoavarone. The semisynthetic compound, as well as the natural metabolites avarone and avarol, were pharmacologically investigated in order to assess their antiparasitic properties against sexual and asexual stages of Plasmodium falciparum, larval and adult developmental stages of Schistosoma mansoni (eggs included), and also against promastigotes and amastigotes of Leishmania infantum and Leishmania tropica. Furthermore, in depth computational studies including density functional theory (DFT) calculations were performed. A toxic semiquinone radical species which can be produced starting both from quinone- and hydroquinone-based compounds could mediate the anti-parasitic effects of the tested compounds.

10 May 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Marcello CasertanoMarcello Casertano
Marcello Casertano
Concetta ImperatoreConcetta Imperatore
Concetta Imperatore
PLPaolo Luciano
Paolo Luciano
Anna AielloAnna Aiello
Anna Aiello
Masteria Yunovilsa PutraMasteria Yunovilsa Putra
Masteria Yunovilsa Putra
Marialuisa MennaMarialuisa Menna
Marialuisa Menna
A deep study of the metabolic content of the tunicate Polycarpa aurata, collected from Indonesian coast, afforded the isolation of two novel alkaloids, polyaurines A (1) and B (2), along with two new p-substituted benzoyl derivatives (3 and 4) and four known compounds (5–8). The structural elucidation of the new secondary metabolites was assigned by 1D, 2D NMR, and HRESIMS techniques. Computational studies resulted a useful tool to unambiguously determine in polyaurine B the presence of rarely found 1,2,4-thiadiazole ring. The effects of polyaurines A and B on mammalian cells growth and on the viability of different blood-dwelling Schistosoma mansoni (phylum: Platyhelminthes) stages, as well as egg production, were evaluated. Both compounds resulted not cytotoxic; interestingly some of the eggs produced by polyaurine A-treated adult pairs in vitro are smaller, deformed, and/or fragmented; therefore, polyaurine A could represent an interesting bioactive natural molecule to be further investigated.

24 September 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MGMassimo Genovese
Massimo Genovese
Concetta ImperatoreConcetta Imperatore
Concetta Imperatore
Marcello CasertanoMarcello Casertano
Marcello Casertano
Anna AielloAnna Aiello
Anna Aiello
Francesco BalestriFrancesco Balestri
Francesco Balestri
Paolo PaoliPaolo Paoli
Paolo Paoli
An in-depth study on the inhibitory mechanism on protein tyrosine phosphatase 1B (PTP1B) and aldose reductase (AR) enzymes, including analysis of the insulin signalling pathway, of phosphoeleganin, a marine-derived phosphorylated polyketide, was achieved. Phosphoeleganin was demonstrated to inhibit both enzymes, acting respectively as a pure non-competitive inhibitor of PTP1B and a mixed-type inhibitor of AR. In addition, in silico docking analyses to evaluate the interaction mode of phosphoeleganin with both enzymes were performed. Interestingly, this study showed that phosphoeleganin is the first example of a dual inhibitor polyketide extracted from a marine invertebrate, and it could be used as a versatile scaffold structure for the synthesis of new designed multiple ligands.

8 March 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Marcello CasertanoMarcello Casertano
Marcello Casertano
MGMassimo Genovese
Massimo Genovese
LPLucia Piazza
Lucia Piazza
Francesco BalestriFrancesco Balestri
Francesco Balestri
Antonella Del CorsoAntonella Del Corso
Antonella Del Corso
Marialuisa MennaMarialuisa Menna
Marialuisa Menna
Diabetes mellitus (DM) represents a complex and multifactorial disease that causes metabolic disorders with acute and long-term serious complications. The onset of DM, with over 90% of cases of diabetes classified as type 2, implies several metabolic dysfunctions leading to consider DM a worldwide health problem. In this frame, protein tyrosine phosphatase 1B (PTP1B) and aldose reductase (AR) are two emerging targets involved in the development of type 2 diabetes mellitus (T2DM) and its chronic complications. Herein, we employed a marine-derived dual type inhibitor of these enzymes, phosphoeleganin, as chemical starting point to perform a fragment-based process in search for new inhibitors. Phosphoeleganin was both disassembled by its oxidative cleavage and used as model structure for the synthesis of a small library of functionalized derivatives as rationally designed analogues. Pharmacological screening supported by in silico docking analysis outlined the mechanism of action against PTP1B exerted by a phosphorylated fragment and a synthetic simplified analogue, which represent the most potent inhibitors in the library.

14 September 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Marcello CasertanoMarcello Casertano
Marcello Casertano
AVAlessio Vito
Alessio Vito
Anna AielloAnna Aiello
Anna Aiello
Concetta ImperatoreConcetta Imperatore
Concetta Imperatore
Marialuisa MennaMarialuisa Menna
Marialuisa Menna
Background: Type 2 diabetes mellitus (T2DM) is an ongoing, risky, and costly health problem that therefore always requires new treatment options. Moreover, although several drugs are available, only 36% of patients achieve glycaemic control, and patient adherence is a major obstacle. With monotherapy, T2DM and its comorbidities/complications often cannot be managed, and the concurrent administration of several hypoglycaemic drugs is required, which increases the risk of side effects. In fact, despite the efficacy of the drugs currently on the market, they generally come with serious side effects. Therefore, scientific research must always be active in the discovery of new therapeutic agents. Discussion: The present review highlights some of the recent discoveries regarding marine natural products that can modulate the various targets that have been identified as crucial in the establishment of T2DM disease and its complications, with a focus on the compounds isolated from marine invertebrates. The activities of these metabolites are illustrated and discussed. Objectives. The paper aims to capture the relevant evidence of the great chemical diversity of marine natural products as a key tool that can advance understanding in the T2DM research field, as well as in antidiabetic drug discovery. The variety of chemical scaffolds highlighted by the natural hits provides not only a source of chemical probes for the study of specific targets involved in the onset of T2DM, but is also a helpful tool for the development of drugs that are capable of acting via novel mechanisms. Thus, it lays the foundation for the design of multiple ligands that can overcome the drawbacks of polypharmacology.